CEA

CEA

Target · Cell adhesion glycoprotein

CEA CEA cell adhesion molecule 5 · carcinoembryonic antigen-related cell adhesion molecule 5

CEA (CEA cell adhesion molecule 5, CEACAM5, CD66e) is a cell surface glycoprotein and the founding member of the carcinoembryonic antigen family. It acts as a cell adhesion molecule and is widely used as a clinical biomarker for gastrointestinal cancers. Browse Assay Genie's current range of CEA research reagents below, or read on for the biology behind the target.

Cell surface glycoproteinCell adhesion moleculeGastrointestinal cancer biomarker
702 aa
Protein length
~77 kDa
Molecular weight
19q13.2
Gene locus
Ig superfamily
Protein family
Target information

What is CEA (CEA cell adhesion molecule 5)?

CEA is a cell surface glycoprotein that functions as a cell adhesion molecule. It is found at the cell membrane, including the apical cell membrane, and may promote tumour development through its adhesive role. It may also regulate differentiation, apoptosis and cell polarity. In the context of microbial infection, CEA serves as a receptor for E. coli Dr adhesins, and binding of these adhesins leads to dissociation of the CEA homodimer.

The CEA gene (CEACAM5) encodes the founding member of the carcinoembryonic antigen family, which belongs to the immunoglobulin superfamily. The gene sits within a CEA family gene cluster on chromosome 19, and alternative splicing gives rise to multiple transcript variants. HGNC classifies it among the CD molecules, the V-set and I-set domain containing groups, and the CEA cell adhesion molecule family. The mouse ortholog is Ceacam5. Researchers studying the CEA protein often compare it with other CEACAM family members that share its domain architecture.

The protein was originally named carcinoembryonic antigen, and the official name is now CEA cell adhesion molecule 5, with the earlier descriptive name carcinoembryonic antigen-related cell adhesion molecule 5 still in use. CD66e is a recognised alias. CEA is used as a clinical biomarker for gastrointestinal cancers, which is why CEA antibody and CEA ELISA kit workflows are common in cancer biology, though its adhesive and polarity-related roles are of interest in their own right.

Gastrointestinal cancer biomarkers

CEA is used as a clinical biomarker for gastrointestinal cancers, making it a standard reference point in tumour marker research.

Tumour cell adhesion

As a cell adhesion molecule, CEA may promote tumour development, so it is studied in adhesion-driven mechanisms of cancer progression.

Cell polarity and differentiation

CEA may regulate differentiation, apoptosis and cell polarity, and it localises to the apical cell membrane.

Host-pathogen interactions

CEA acts as a receptor for E. coli Dr adhesins, and adhesin binding dissociates the homodimer.

Background

CEA frequently asked questions

What does CEA do?

CEA is a cell surface glycoprotein that works as a cell adhesion molecule and may promote tumour development. It may also regulate differentiation, apoptosis and cell polarity. It is also a receptor for E. coli Dr adhesins, whose binding dissociates the CEA homodimer.

What are the other names for CEA and its gene?

The gene symbol is CEACAM5, and the protein is also called CD66e or CEA. The full name is CEA cell adhesion molecule 5, previously carcinoembryonic antigen-related cell adhesion molecule 5. Alternative splicing produces multiple transcript variants.

Is CEA linked to disease and conserved in other species?

CEA is used as a clinical biomarker for gastrointestinal cancers and may promote tumour development as a cell adhesion molecule. The mouse ortholog is Ceacam5; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other CEA family cell adhesion molecules from the same gene cluster, relevant to cancer biomarker and adhesion research.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P06731; product specifications from Assay Genie datasheets.

CEA Product listing